Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

July 31, 2023 6:22 (London Time)

Avenue Therapeutics

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: ATXI
Sentiment: -0.0772
MarketCap: 8,554,123.0
High: 1.09 Low: 1.02

Open: 1.05 Close: 1.08 Change: 0.03

Our AI found some flaws in Avenue Therapeutics.

Are looking for the most relevant information about Avenue Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Avenue Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Avenue Therapeutics are: Avenue, Therapeutics, Inc, close, new, study, IV, and the most common words in the summary are: excipient, therapeutic, avenue, phase, sodium, overview, polysorbate, . One of the sentences in the summary was: Avenue Theraputics provides regulatory update on IV tramadol.. Other searches related …

Concept Map

...

Semantic Network

...

Stock Summary

Avenue Therapeutics, Inc. develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. AJ201, AJ201 is in a Phase 1b/2a clinical trial for the. treatment of.

Today's Summary

Avenue Therapeutics Inc has fallen 3.57% over the past month. AvexI currently has the 123th highest Short-Term Technical score. Avenue Theraputics provides regulatory update on IV tramadol.

Today's News

Avenue Therapeutics Inc has fallen 3.57% over the past month, closing at $1.14 on June 29. The discovery opens a new avenue for Parkinsons therapeutics, scientists report in a new study. AvexI currently has the 123th highest Short-Term Technical score. Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates. Avenue Theraputics provides regulatory update on IV tramadol. Avenue Therapeutics, Inc. (NASDAQ:ATXI) announces closing of $12 Million Underwritten Public Offering of Common Stock. A recent study used genet to diagnose Kennedys Disease. Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis (GlobeNewswire) Nov-13-20: Read This Before Selling Avenue Therapies, Inc. (NASDAQ:ATXI) Shares.

Stock Profile

"Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida."

Keywords

This document will help you to evaluate Avenue Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Avenue Therapeutics are: Avenue, Therapeutics, Inc, close, new, study, IV, and the most common words in the summary are: excipient, therapeutic, avenue, phase, sodium, overview, polysorbate, . One of the sentences in the summary was: Avenue Theraputics provides regulatory update on IV tramadol.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #excipient #therapeutic #avenue #phase #sodium #overview #polysorbate.

Read more →

Related Results

...
January 30, 2024 13:24 (London Time)

Avenue Therapeutics

Avenue Theraputics stock price has decreased by -88.52% in the past year. AvexXI trades on the NASDAQ under the ticker symbol ATXI. AveXI stock quot…
Sector: Pharmaceuticals
Ticker: ATXI
Sentiment: 0.296
MarketCap: 5,703,990.0
High: 0.16 Low: 0.14

Open: 0.15 Close: 0.15 Change: 0.0

Read more →
...
July 31, 2023 6:22 (London Time)

Avenue Therapeutics

Avenue Therapeutics Inc has fallen 3.57% over the past month. AvexI currently has the 123th highest Short-Term Technical score. Avenue Theraputics p…
Sector: Pharmaceuticals
Ticker: ATXI
Sentiment: -0.0772
MarketCap: 8,554,123.0
High: 1.09 Low: 1.02

Open: 1.05 Close: 1.08 Change: 0.03

Read more →
...
December 22, 2023 6:27 (London Time)

Avenue Therapeutics

Avenue Therapeutics (ATXI) stock up 59% today. The first publicly traded biotechnology company organized as a public benefit corporation.
Sector: Pharmaceuticals
Ticker: ATXI
Sentiment: 0.4588
MarketCap: 1,870,564.0
High: 0.15 Low: 0.14

Open: 0.14 Close: 0.14 Change: 0.0

Read more →
...
May 09, 2023 4:10 (London Time)

Avenue Therapeutics

Avenue Therapeutics trades on the NASDAQ under the ticker symbol ATXI. Avenue Theraputics stock was originally listed at a price of $123.74 in Jun 2…
Sector: Pharmaceuticals
Ticker: ATXI
Sentiment: 0.8655
MarketCap: 5.72M
High: 1.04 Low: 1.0

Open: 1.02 Close: 1.02 Change: 0.0

Read more →